INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 29 filers reported holding INFLARX NV in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,876,413 | $54,116,000 | 31.91% |
| RA Capital Management | 1,620,653 | $46,740,000 | 3.58% |
| Cormorant Asset Management, LP | 1,399,030 | $40,348,000 | 3.01% |
| EMORY UNIVERSITY | 90,761 | $2,618,000 | 1.87% |
| Redmile Group, LLC | 851,100 | $24,546,000 | 0.95% |
| Eventide Asset Management | 275,000 | $7,931,000 | 0.37% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,394,132 | $40,207,000 | 0.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,500 | $2,552,000 | 0.09% |
| Baker Brothers Advisors | 200,000 | $5,768,000 | 0.05% |
| Artal Group S.A. | 125,000 | $3,605,000 | 0.04% |